MaxLinear (MXL) Stock Sees Revenue Jump Test Bullish Profitability Narrative After Q2 Return To Profit

MaxLinear (MXL) opened Q2 2026 with total revenue of US$168.8 million and basic EPS of US$0.02, alongside net income of US$1.8 million. The company has seen quarterly revenue move from US$108.8 million in Q2 2025 to US$126.5 million in Q3, US$136.4 million in Q4, US$137.2 million in Q1 2026 and now US$168.8 million. EPS shifted from a loss of US$0.31 in Q2 2025 to losses of US$0.52, US$0.17 and US$0.52 before returning to a small profit this quarter. For investors, that mix of higher sales and a move back into the black on a quarterly basis puts the focus squarely on whether margins can hold and extend from here.

See our full analysis for MaxLinear.

With the headline numbers on the table, the next step is to see how MaxLinear's latest margins and growth trajectory compare with the widely followed bullish and bearish narratives around the stock.

See what the community is saying about MaxLinear

Losses On The Trailing Year Still Matter For MaxLinear

• On a trailing twelve month basis to Q2 2026, MaxLinear booked total revenue of US$568.9 million and a net loss of US$103.8 million, with basic EPS at a loss of US$1.18.
• Bears point out that these trailing losses, which increased over the past five years at about 48.6% per year, sit uncomfortably alongside forecasts for earnings to grow around 82.9% per year and for profitability within three years. This raises questions about how quickly a business that just reported a US$103.8 million loss can shift to the positive side.
  • Critics highlight that while revenue is forecast to grow about 22.9% per year, the current trailing loss means any earnings recovery starts from a deeply negative base.
  • The bearish view stresses that recent quarterly losses such as the Q1 2026 loss of US$45.1 million still feed into the trailing figures, so one profitable quarter does not yet overturn the longer loss trend.

For readers who see the latest profit but are weighing those multi year losses, the detailed cautious narrative on MaxLinear adds useful context before drawing conclusions about the road ahead. 🐻 MaxLinear Bear Case

Revenue Run Rate Vs 22.9% Growth Story

• Quarterly revenue has moved from US$95.9 million in Q1 2025 to US$168.8 million in Q2 2026, and the latest trailing twelve month revenue sits at US$568.9 million against forecasts that revenue could grow about 22.9% per year from here.
• Supporters of the bullish narrative argue that expected revenue growth of around 24.6% annually in some optimistic scenarios fits with this ramp in quarterly sales. At the same time, the fact that trailing EPS is still a loss of US$1.18 suggests the move from losses such as US$49.7 million in Q1 2025 to a Q2 2026 profit of US$1.8 million needs to be sustained before the growth story looks firmly backed by earnings.
  • What stands out for bullish investors is that Q2 2026 revenue of US$168.8 million is well above the US$108.8 million reported in Q2 2025, which aligns with narratives that MaxLinear could support higher sales levels if demand for its products holds.
  • At the same time, trailing net losses of US$103.8 million contrast with bullish expectations that margins could move from a loss of about 26% today to positive double digits in a few years, so the current data leaves that margin shift as something investors will watch in coming periods.

If you want to see how optimistic investors connect this revenue ramp to future profitability for MaxLinear, the dedicated bullish narrative is a helpful next stop. 🐂 MaxLinear Bull Case

Rich P/S Multiple And DCF Gap

• At a current share price of US$71.59, MaxLinear trades on a P/S of 11.4x compared with about 7.6x for the semiconductor industry and 6x for peers, while the provided DCF fair value is US$57.70.
• Consensus narrative views that highlight strong forecast revenue and earnings growth are tested by this combination of a P/S premium and a DCF figure below the current price. Investors are effectively paying a higher multiple for a company that is still loss making on a trailing basis with EPS at a loss of US$1.18.
  • Supporters of the consensus view may point to the forecast revenue growth of roughly 24% per year and expected earnings of around US$101.8 million in several years, but the trailing net loss of US$103.8 million shows the business has not yet reached that phase.
  • On the risk side, recent share price volatility and insider selling over the last three months add to the picture of a stock where expectations are already high relative to both peers and the DCF fair value of US$57.70.

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for MaxLinear on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

Given the mix of cautious and optimistic views around MaxLinear, it may be helpful to review the data yourself and decide what feels reasonable for your portfolio. To see how those concerns and potential upsides compare in one place, take a closer look at the 1 key reward and 2 important warning signs.

See What Else Is Out There Beyond MaxLinear

MaxLinear still carries trailing losses of US$103.8 million, a loss per share of US$1.18 and a P/S multiple that sits above peers and its DCF figure.

If those ongoing losses and the rich revenue multiple make you uneasy, you may want to shift some research time toward stocks with stronger upside potential and value support by checking the 49 high quality undervalued stocks.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com